Injective Weekly Chart Breakdown: INJ Eyes $17.30 Long-Term Recovery

Injective (INJ) is facing a notable decline, continuing its downward price trajectory. Over the past 24 hours, the token has declined by nearly 9.7%, with a corresponding weekly performance decrease of 7.91%. Bears appear to be dominating as traders adjust to persistent selling pressure across markets.

Currently, INJ is trading at $4.68, with a 24-hour trading volume reaching $65.04 million, reflecting a sharp 54.51% increase in activity. Despite higher trading, its market capitalization has fallen to $468.85 million, down 9.7%, indicating shrinking investor confidence amid ongoing market volatility and short-term bearish sentiment.

Also Read: Massive Token Unlocks to Inject $1.69 Billion into Crypto Market

Technical Outlook Shows Bearish Momentum

Injective remains in a clear weekly downtrend, with price trading near $4.70 and holding below all major moving averages. The structure shows consistently lower highs and lower lows since the peak near $35. Selling pressure intensified after the Q4 breakdown, followed by weak consolidation, signaling bearish continuation rather than accumulation.

The moving average ribbon further accentuates the bear dominance in the market for the asset. In particular, the 20-day simple moving average (SMA) is seen around $7.62, the 50-day SMA around $10.22, the 100-day SMA around $12.96, and the 200-day SMA around $17.31.

The current market price remains well below all the aforementioned important moving averages, and the moving average ribbon appears to be greatly expanded.

On the flip side, the closest support level is pegged between $4.20 and $4.50. In the event that the price falls below this level, the next targets will be $3.30 and then $3.00. During relief rallies, the resistance levels will be at $5.80, $7.60, $10.20, and finally $13.00. A totally new trend would only be considered if the price closes above $17.30 on a weekly close.

New Tokenomics Upgrade Accelerates INJ Deflation

Injective is asserting its dominance in the crypto landscape by making a series of strategic moves. Institutional-grade partnerships are expanding, and a new tokenomics upgrade that has been rolled out is accelerating the deflation of INJ. All these factors are strengthening the fundamentals of the network and propelling Injective to become one of the top players in innovative decentralized finance.

In addition to the promotion of ecosystem development, the Injective team is actively working to help shape policy by meeting directly with the U.S. Securities and Exchange Commission. At the same time, the community is very motivated, and the ninjas have continued to build tirelessly in the pursuit of a worldwide, efficient, and inclusive financial system.

Also Read: Injective Faces Volatility, Strong Move Could Hit $6.335